Congenital adrenal hypoplasia

Gene: HSD3B2

Red List (low evidence)

HSD3B2 (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2)
EnsemblGeneIds (GRCh38): ENSG00000203859
EnsemblGeneIds (GRCh37): ENSG00000203859
OMIM: 613890, Gene2Phenotype
HSD3B2 is in 2 panels

2 reviews

Ellen McDonagh (Genomics England Curator)

Comment on list classification: Demoted to red, as it is related to adrenal hyperplasia rather than adrenal hypoplasia.
Created: 6 Feb 2017, 2:27 p.m.
Comment on list classification: >3 unrelated cases reported, and is green on the Disorders of sex development gene panel Version 1.4.
Created: 2 Feb 2017, 2:18 p.m.

John Achermann (UCL Institute of Child Health)

Red List (low evidence)

Typically causes adrenal insufficiency as part of 3-beta hydroxysteroid dehydrogenase type 2 deficiency. Approximately 50% of children will have salt loss in addition to glucocorticoid insufficiency. Can cause mild androgenization in 46,XX infants or hypospadias in 46,XY infants. A form of congenital adrenal HYPERplasia that should be diagnosed on biochemical patterns but may be misdiagnosed as adrenal hypoplasia in rare situations, especially in girls with no clitoral enlargement.
Created: 7 Dec 2015, 2:55 p.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Red
Phenotypes
  • Adrenal hyperplasia, Congenital, Due To 3-beta-Hydroxysteroid Dehydrogenase Deficiency type 2 with or without salt-loss
  • variabe effects on sex steroid synthesis
  • Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency 201810
OMIM
613890
Clinvar variants
Variants in HSD3B2
Penetrance
Complete
Panels with this gene

History Filter Activity

6 Feb 2017, Gel status: 1

panel promoted to version 1

Ellen McDonagh (Genomics England Curator)

06/02/2016: Panel revised according to expert review, further curation and discussion with Clinical Geneticists at Genomics England. Ready to promote to version 1.

6 Feb 2017, Gel status: 1

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Red List (Low Evidence).

6 Feb 2017, Gel status: 1

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Red List (Low Evidence).

2 Feb 2017, Gel status: 2

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Amber List (Moderate Evidence).

2 Feb 2017, Gel status: 0

Set Phenotypes

Ellen McDonagh (Genomics England Curator)

Phenotypes for HSD3B2 were set to Adrenal hyperplasia, Congenital, Due To 3-beta-Hydroxysteroid Dehydrogenase Deficiency type 2 with or without salt-loss; variabe effects on sex steroid synthesis;Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency 201810

25 Jan 2017, Gel status: 0

Approved Gene

Ellen McDonagh (Genomics England Curator)

This proposed gene was validated and added to this panel

7 Dec 2015, Gel status: 0

Set Phenotypes

Ellen McDonagh (Genomics England Curator)

Phenotypes for gene HSD3B2 were set to Adrenal hyperplasia, Congenital, Due To 3beta-Hydroxysteroid Dehydrogenase Deficiency type 2 with or without salt-loss; variabe effects on sex steroid synthesis

7 Dec 2015, Gel status: 0

Created

John Achermann (UCL Institute of Child Health)

HSD3B2 was created by John Achermann

7 Dec 2015, Gel status: 0

Added New Source

John Achermann (UCL Institute of Child Health)

HSD3B2 was added to Congenital adrenal hypoplasiapanel. Sources: Expert list